Related Experiment Video
Updated: Sep 12, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
[Inherited metabolic liver disease causing copper deposition]
1First Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
This review explores inherited metabolic liver diseases causing copper deposition beyond Wilson's disease. It details their pathogenesis and differential diagnosis for better clinical and pathological identification.
Area of Science:
- Biochemistry
- Hepatology
- Genetics
Background:
- Copper is an essential trace element vital for enzyme function, with the liver central to its metabolism.
- Metabolic dysfunctions in copper absorption, transport, or excretion can lead to organ deposition or deficiency.
- Wilson's disease is characterized by hepatic copper deposition, but other conditions also present with this finding.
Purpose of the Study:
- To review inherited metabolic liver diseases associated with hepatic copper deposition.
- To elucidate the pathogenesis of copper accumulation in these non-Wilsonian diseases.
- To outline clinical and pathological approaches for differential diagnosis.
Main Methods:
- Literature review of inherited metabolic liver diseases causing copper deposition.
- Analysis of pathogenesis related to copper metabolism.
- Synthesis of clinical and pathological diagnostic criteria.
Main Results:
- Identified several inherited metabolic liver diseases, distinct from Wilson's disease, that result in hepatic copper accumulation.
- Detailed the specific molecular and physiological mechanisms driving copper deposition in these conditions.
- Highlighted key clinical and pathological features aiding in differentiating these diseases.
Conclusions:
- Hepatic copper deposition is not exclusive to Wilson's disease and occurs in various inherited metabolic liver diseases.
- Understanding the distinct pathogenesis is crucial for accurate diagnosis.
- A combined clinical and pathological approach is essential for effective differential diagnosis.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
07:27The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Related Concept Videos
Inborn Errors of Metabolism
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Lysosomal Hydrolases
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...